VetSheet

Lithium

Lithium carbonate

Haematopoietic agentPODogsCats

Also known as: Camcolit Β· Liskonum Β· Priadel Β· Lithium Β· Li2CO3

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

10 mg/kgPOΒ· q12h
β€” πŸ•

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

🌎 NA β€” North America🌍 EU β€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Bone marrow suppression / neutropenia10 mg/kgPOq12hβ€”πŸŒ EU
  • Bone marrow suppression / neutropenia: Give with food.

Cats

IndicationDoseRouteFrequencyDurationRegion
ContraindicatedDo not usePOβ€”β€”πŸŒ EU
  • Contraindicated: Lithium is toxic to cats.

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Lithium carbonate is primarily used in veterinary medicine to stimulate bone marrow production. It is indicated for the treatment of idiopathic aplastic anaemia, cytotoxic drug-induced neutropenia or thrombocytopenia, oestrogen-induced bone marrow suppression, and cyclic haemopoiesis.

Clinical Warning: There is a lag phase of up to 4 weeks before its clinical effects may be seen.

Experimental studies suggest lithium may prevent neutropenia associated with cytotoxic drugs when administered concomitantly, though robust clinical trials are lacking.

Clinical Pearl: The recommended therapeutic serum lithium concentration is 0.5-1.8 mmol/l, which should be assessed every 3 months if possible.

Mechanism of action

Lithium stimulates bone marrow stem cells, causing an increase in the production of haemopoietic cell lines β†’ particularly granulocytes.

Safety & warnings

Contraindications

  • Cats (highly toxic)
  • Renal impairment
  • Cardiac disease
  • Conditions with sodium imbalance (e.g., hypoadrenocorticism)
  • Dehydration

Adverse effects

  • Nausea
  • Diarrhoea
  • Muscle weakness
  • Fatigue
  • Polyuria (PU)
  • Polydipsia (PD)
  • Seizures
  • Hypothyroidism (blocks release of T3 and T4)

Precautions

WARNING: Do not use in cats as lithium is highly toxic to them.

WARNING: Avoid in patients with renal impairment, cardiac disease, or sodium imbalance. Only use in patients showing no signs of dehydration.

  • Therapeutic Monitoring: Assess serum lithium concentration every 3 months (target: 0.5-1.8 mmol/l).
  • Thyroid Monitoring: Assess thyroid status every 6 months, as lithium can block the release of T3 and T4.

Drug interactions

ACE inhibitorsMajor

Reduces lithium excretion, increasing the risk of toxicity

Loop diureticsMajor

Reduces lithium excretion and causes sodium depletion, worsening toxicity

Thiazide diureticsMajor

Reduces lithium excretion and causes sodium depletion, worsening toxicity

NSAIDsMajor

Reduces lithium excretion, increasing the risk of toxicity

TheophyllineModerate

May increase the excretion of lithium, potentially reducing efficacy

NeostigmineModerate

Lithium antagonizes the effects of neostigmine

PyridostigmineModerate

Lithium antagonizes the effects of pyridostigmine

DiltiazemMajor

Concurrent administration may result in neurotoxicity

VerapamilMajor

Concurrent administration may result in neurotoxicity

Monitoring

  • Serum lithium concentration (target 0.5-1.8 mmol/l, assess every 3 months)
  • Thyroid status (T3 and T4, assess every 6 months)
  • Renal function
  • Hydration status and serum sodium levels

Overdose

Lithium is nephrotoxic at high doses. Toxicity is significantly worsened by sodium depletion (e.g., concurrent diuretic use or dehydration). Signs of toxicity may include severe nausea, diarrhoea, muscle weakness, polyuria/polydipsia, and seizures.

Available products

Formulations

  • 250 mg oral tablet
  • 400 mg oral tablet

Human-labeled

  • Camcolit 250 mg tablet
  • Camcolit 400 mg tablet
  • Liskonum 450 mg tablet (strength varies by region)
  • Priadel 200 mg tablet
  • Priadel 400 mg tablet

Regulatory status

European Unionβœ“ ApprovedPrescription onlyEMA

Human authorized products used off-label under the cascade (POM).

United Kingdomβœ“ ApprovedPrescription onlyVMD

Human authorized products used off-label under the cascade (POM).

No regulatory data for: πŸ‡ΊπŸ‡Έ US Β· πŸ‡­πŸ‡° HK Β· πŸ‡ΉπŸ‡Ό TW Β· πŸ‡―πŸ‡΅ JP Β· πŸ‡°πŸ‡· KR Β· πŸ‡¦πŸ‡Ί AU

Storage & stability

Normal precautions should be observed. Store at room temperature away from moisture and heat.

Client information

Give this medication with food to reduce stomach upset.

It may take up to 4 weeks before the medication starts working to improve your dog's blood cell counts.

Watch your dog closely for signs of excessive drinking and urination, muscle weakness, extreme tiredness, or seizures, and contact your veterinarian immediately if these occur.

Do not give this medication to cats, as it is highly toxic to them. Keep all follow-up appointments, as your dog will need regular blood tests to check the drug levels and thyroid function.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.